Intralytix and BioPhage partner to develop bacteriophage treatments of human wounds infected with S. aureus

Intralytix, Inc. announced that the Company is partnering with BioPhage Therapeutics Limited to deve...

Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017

Ascendis Pharma A/S ,biopharmaceutical company that utilizes its innovative TransCon technology to a...

Teva announces FDA approval of Austedo tablets for chorea associated with huntington’s disease

Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has approved AUSTEDO™ (deutetrabenaz...

Aurinia Announces Development Plans for Voclosporin in Europe and Japan

Aurinia Pharmaceuticals Inc announced the outcome of discussions with both the EMA and the PMDA in J...

Medidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year”

Medidata the leading global provider of cloud-based technology and data analytics for clinical resea...

  • Intralytix and BioPhage partner to develop bacteriophage treatments of human wounds infected with S. aureus

  • Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017

  • Teva announces FDA approval of Austedo tablets for chorea associated with huntington’s disease

  • Aurinia Announces Development Plans for Voclosporin in Europe and Japan

  • Medidata Wins Informa CARE Award for “Clinical Trial Partnership of the Year”

Projects

The Emmes Corporation Wins $70 Million Contract for Pediatric Research

The Emmes Corporation announced that it was awarded a contract from the National Institutes of Health to support pediatric clinical trials sponsored by the National Institute of Child Health and Human

Read more »
NuMedii, Inc. Announces New Partnership To Discover New Treatments For Idiopathic Pulmonary Fibrosis

NuMedii, Inc announced the formation of a strategic partnership with Three Lakes Partners, LLC, to discover and advance new treatments for idiopathic pulmonary fibrosis (IPF) based on NuMedii’s

Read more »
Amri Announces Strategic Alliance To Advance Mass Spectrometry Capabilities For Drug Discovery

AMRI , a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker Daltonics and HighRes Biosolutions to deve

Read more »

News

CARsgen Launches First-in-Class Anti-Claudin18.2 CAR-T Clinical Trial

CARsgen Therapeutics (CARsgen), a global leader in developing chimeric antigen receptor T-cell (CAR-T cell) therapies for solid tumors announced its first-in-class anti-Claudin18.2-CAR-T cell therapy

Read more »
The Great Hall of China: double digit growth at CPhI China

CPhI and P-MEC China , UBM Sinoexpo,CCCMHPIE,Chinese pharmaceutical market development,Asia’s largest pharma eventCPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China Chamber of Comme

Read more »
First FDA-Approved Treatment for ALS in 22 Years Now Available in U.S

Mitsubishi Tanabe Pharma America, Inc. announced RADICAVA ™ (edaravone), an intravenous therapy indicated for all adult patients diagnosed with amyotrophic lateral sclerosis (ALS), also kn

Read more »

Market Reports

Alvogen Announces Acquisition to Expand Russian Business

Alvogen announced today that it has signed a definitive agreement to acquire Omega Bittner, a Russia-based pharmaceutical firm owned by Perrigo Company plc. Working with well-established and recogni

Read more »
Bristol-Myers Squibb acquires IFM Therapeutics

BMS Company and IFM Therapeutics announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of IFM Therapeutics.

Read more »
KBI Biopharma Acquires Alliance Protein Laboratories, Expands Biophysical Capabilities

KBI Biopharma, Inc. (KBI) has agreed to acquire the assets of San Diego-based Alliance Protein Laboratories (Alliance), a leading analytical services company specializing in biophysical characterizati

Read more »

Press Releases

A New Drug Research And Development Cooperation Reached By Chengdu Pilot And Aduro

Chengdu Pioneer Drug Development Co., Ltd. announced a multi-year, long-term, new drug research and development collaboration with Aduro Biotech to achieve a new small molecule lead compound for these

Read more »
FDA Approval Of CaroSpir Announced By CMP Pharma , Inc.

CMP Pharma announced that the US FDA has granted final approval of the company’s NDA for CaroSpir® (Spironolactone Oral Suspension, 25 mg/5mL), the first and only FDA-approved oral liquid dosage fo

Read more »
Takeda and Molecular templates announce research and collaboration to develop next-generation oncology therapies

Takeda Pharma and Molecular Templates, Inc. announced a collaboration agreement for oncology drug discovery programs. The collaboration will apply Molecular Templates’ETB technology platform to pote

Read more »

Featured Events

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: